Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN‐α therapy
Jin‐Ying Lu(National Taiwan University Hospital), Mei–Hsuan Lee(National Taiwan University), Wei‐Shiung Yang(National Taiwan University), Pei‐Jer Chen(National Taiwan University), Jia‐Horng Kao(National Taiwan University Hospital), Tong‐Yuan Tai, Cha‐Ze Lee, Ming–Yang Lai(National Taiwan University Hospital), Lee‐Ming Chuang(National Taiwan University)
Cited by 32
Related Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis
|The Lancet Neurology|2008|726
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569